Skip to main content
Premium Trial:

Request an Annual Quote

Keygene Buys 454 Sequencer; First Sequencer 20 Placement for Roche in Europe

NEW YORK, Jan. 9 (GenomeWeb News) - Keygene purchased 454's Genome Sequencer 20 system from Roche Diagnostics, the companies announced today.


Keygene is Roche's first European customer for the sequencing system.


The Genome Sequencer 20 System takes a nanotechnology based approach to sequencing and was developed by 454 Life Sciences. The system sequences over 20 million bases within a four and a half hour run, Roche said.


Roche, 454 Life Sciences, and Kegene will use the system with Keygene's AFLP and SNPWave technologies to develop applications in plant genetics.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.